Vivani Medical is trading 5.15% higher at $1.43, mainly in line with biotech strength as XBI rises 2.75%.
- No new company-specific announcement was identified for September 2, 2026.
- Latest listed releases cover its August 13 second-quarter results and SLIM-1 clinical progress, not a new catalyst today.
- Broader U.S. equities are rebounding in a risk-on move, while elevated rates and geopolitical uncertainty remain market risks.